Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_assertion type Assertion NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_head.
- NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_assertion wasGeneratedBy ECO_0000203 NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_provenance.
- NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_assertion wasDerivedFrom befree-2016 NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_provenance.
- NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_assertion SIO_000772 21715317 NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_provenance.
- NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_assertion evidence source_evidence_literature NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_provenance.
- NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_assertion description "[CD160 positivity was significantly higher in CLL and HCL in terms of percentage (65.9% and 67.8%, respectively, P < .0001) and median fluorescence intensity (552 and 857, respectively, P < .0001) compared with all other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905882.RAeZoUpMTQzD7ftfgLgTa3eF_x8T95Tylp9lznAcvH5co130_provenance.